Neurocrine Biosciences
NBIX
#1636
Rank
NZ$22.94 B
Marketcap
NZ$230.12
Share price
-0.72%
Change (1 day)
-10.25%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company